» Articles » PMID: 19956818

The Role of Opioids in Managing Chronic Non-cancer Pain

Overview
Specialty General Medicine
Date 2009 Dec 4
PMID 19956818
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

The use of opioids for the treatment of chronic non-cancer pain has become more widespread recently. Available data support the short-term use of opioids in clearly defined nociceptive and neuropathic pain states. Their use in 'pathological' pain states without a clear diagnosis, such as chronic low back pain, is more contentious. A decision to initiate opioid treatment in these conditions requires careful consideration of benefits and risks; the latter include not only commonly considered adverse effects such as constipation, but also opioid-induced hyperalgesia, abuse, addiction and diversion. Ideally, treatment goals should not only be relief of pain, but also improvement of function. Opioid treatment of chronic non-cancer pain requires informed consent by, and preferably a treatment contract with, the patient. Treatment should be initiated by a trial period with defined endpoints using slow-release or transdermal opioids. Ongoing management of the patient requires ideally a multi-disciplinary setting. Treatment should not be regarded as life-long and can be discontinued by tapering the dose.

Citing Articles

Novel quinoxaline derivatives as dual EGFR and COX-2 inhibitors: synthesis, molecular docking and biological evaluation as potential anticancer and anti-inflammatory agents.

Ahmed E, Mohamed M, Omran O RSC Adv. 2022; 12(39):25204-25216.

PMID: 36199335 PMC: 9443684. DOI: 10.1039/d2ra04498f.


Synthesis, crystallographic characterization, molecular docking and biological activity of isoquinoline derivatives.

Abuelizz H, Al-Salahi R, Al-Asri J, Mortier J, Marzouk M, Ezzeldin E Chem Cent J. 2017; 11(1):103.

PMID: 29086866 PMC: 5643734. DOI: 10.1186/s13065-017-0321-1.


Impact of Treatment with Naloxegol for Opioid-Induced Constipation on Patients' Health State Utility.

Lawson R, King F, Marsh K, Altincatal A, Cimen A Adv Ther. 2016; 33(8):1331-46.

PMID: 27342744 PMC: 4969326. DOI: 10.1007/s12325-016-0365-y.


Development of opioid-induced constipation: post hoc analysis of data from a 12-week prospective, open-label, blinded-endpoint streamlined study in low-back pain patients treated with prolonged-release WHO step III opioids.

Ueberall M, Mueller-Schwefe G J Pain Res. 2015; 8:459-75.

PMID: 26300655 PMC: 4536845. DOI: 10.2147/JPR.S88076.


Oxycodone/Naloxone: role in chronic pain management, opioid-induced constipation, and abuse deterrence.

DePriest A, Miller K Pain Ther. 2014; 3(1):1-15.

PMID: 25135384 PMC: 4108020. DOI: 10.1007/s40122-014-0026-2.